Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Cefdinir

A third-generation oral cephalosporin born in Japan: patented in 1979, first approved in 1991 and in the United States in 1997, it is used for ear infections, sinusitis, sore throat, pneumonia and skin infections. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?In the gut it can bind to iron, for instance from iron-fortified infant formula, forming a compound that turns stools a rusty red.

CefdinirGo to the active ingredient →
CefdinirActive ingredientCefdinirCat. No. P-C079-001CAS 91832-40-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.